StonvexLoading…
StonvexCore line items from JAZZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.27B | $4.07B | $3.83B | $3.66B |
Operating Income | $-430.24M | $716.63M | $578.58M | $-65.53M |
Net Income | $-356.15M | $560.12M | $414.83M | $-224.06M |
EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 |
Total Assets | $11.66B | $12.01B | $11.39B | $10.84B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881.48M |
Free Cash Flow OCF − CapEx | $1.30B | $1.36B | $1.07B | $1.24B |
Shares Outstanding | 61.44M | 60.63M | 62.26M | 63.21M |